PF9 tetrasodium salt

Potent GPR17 agonist CAS# 851265-78-6

PF9 tetrasodium salt

Catalog No. BCC7854----Order now to get a substantial discount!

Product Name & Size Price Stock
PF9 tetrasodium salt: 5mg $1495 In Stock
PF9 tetrasodium salt: 10mg Please Inquire In Stock
PF9 tetrasodium salt: 20mg Please Inquire Please Inquire
PF9 tetrasodium salt: 50mg Please Inquire Please Inquire
PF9 tetrasodium salt: 100mg Please Inquire Please Inquire
PF9 tetrasodium salt: 200mg Please Inquire Please Inquire
PF9 tetrasodium salt: 500mg Please Inquire Please Inquire
PF9 tetrasodium salt: 1000mg Please Inquire Please Inquire
Related Products
  • S 32826

    Catalog No.:BCC7678
    CAS No.:1103672-43-0
  • HA 130

    Catalog No.:BCC7884
    CAS No.:1229652-21-4

Quality Control of PF9 tetrasodium salt

Number of papers citing our products

Chemical structure

PF9 tetrasodium salt

3D structure

Chemical Properties of PF9 tetrasodium salt

Cas No. 851265-78-6 SDF Download SDF
PubChem ID 90488909 Appearance Powder
Formula C18H16N5Na4O13P3 M.Wt 695.23
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble in water (supplied pre-dissolved at a concentration of 10mM)
Chemical Name tetrasodium;[[[(2R,3S,4R)-5-[6-amino-2-(2-phenylethynyl)purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate
SMILES C1=CC=C(C=C1)C#CC2=NC3=C(C(=N2)N)N=CN3C4C(C(C(O4)COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O)O.[Na+].[Na+].[Na+].[Na+]
Standard InChIKey ONTPGXYSNYMMOK-YEJXUIBNSA-J
Standard InChI InChI=1S/C18H20N5O13P3.4Na/c19-16-13-17(22-12(21-16)7-6-10-4-2-1-3-5-10)23(9-20-13)18-15(25)14(24)11(34-18)8-33-38(29,30)36-39(31,32)35-37(26,27)28;;;;/h1-5,9,11,14-15,18,24-25H,8H2,(H,29,30)(H,31,32)(H2,19,21,22)(H2,26,27,28);;;;/q;4*+1/p-4/t11-,14-,15-,18?;;;;/m1..../s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of PF9 tetrasodium salt

DescriptionPotent agonist of GPR17 (EC50 = 36 pM).

PF9 tetrasodium salt Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

PF9 tetrasodium salt Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of PF9 tetrasodium salt

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.4384 mL 7.1919 mL 14.3837 mL 28.7675 mL 35.9593 mL
5 mM 0.2877 mL 1.4384 mL 2.8767 mL 5.7535 mL 7.1919 mL
10 mM 0.1438 mL 0.7192 mL 1.4384 mL 2.8767 mL 3.5959 mL
50 mM 0.0288 mL 0.1438 mL 0.2877 mL 0.5753 mL 0.7192 mL
100 mM 0.0144 mL 0.0719 mL 0.1438 mL 0.2877 mL 0.3596 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on PF9 tetrasodium salt

Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor.[Pubmed:20394377]

J Med Chem. 2010 May 13;53(9):3489-501.

The application of frontal affinity chromatography-mass spectrometry (FAC-MS), along with molecular modeling studies, to the screening of potential drug candidates toward the recently deorphanized G-protein-coupled receptor (GPCR) GPR17 is shown. GPR17 is dually activated by uracil nucleotides and cysteinyl-leukotrienes, and is expressed in organs typically undergoing ischemic damage (i.e., brain, heart and kidney), thus representing a new pharmacological target for acute and chronic neurodegeneration. GPR17 was entrapped on an immobilized artificial membrane (IAM), and this stationary phase was used to screen a library of nucleotide derivatives by FAC-MS to select high affinity ligands. The chromatographic results have been validated with a reference functional assay ([(35)S]GTPgammaS binding assay). The receptor nucleotide-binding site was studied by setting up a column where a mutated GPR17 receptor (Arg255Ile) has been immobilized. The chromatographic behavior of the tested nucleotide derivatives together with in silico studies have been used to gain insights into the structure requirement of GPR17 ligands.

Keywords:

PF9 tetrasodium salt,851265-78-6,Natural Products,Orphan 7-TM Receptors, buy PF9 tetrasodium salt , PF9 tetrasodium salt supplier , purchase PF9 tetrasodium salt , PF9 tetrasodium salt cost , PF9 tetrasodium salt manufacturer , order PF9 tetrasodium salt , high purity PF9 tetrasodium salt

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: